Track record
Konstantin Poukalov
An officer, director or large holder of 4 blank-check companies. Every role below was declared by Konstantin Poukalov in an SEC ownership filing.
Vehicles
4
Still live
0
Closed a deal
3 of 4
Capital involved
$490M
Every vehicle, newest first
- ARYA Sciences Acquisition Corp V— · Chief Business Officer · IPO Jul 14, 2021$153MLiquidated
- ARYA Sciences Acquisition Corp IV— · Chief Business Officer · IPO Mar 1, 2021$37.1MCompleted
- Nautilus Biotechnology, Inc.NAUT · Chief Business Officer · IPO Aug 10, 2020$150MCompleted
- Cerevel Therapeutics Holdings, Inc.— · Chief Business Officer · IPO Jun 8, 2020$150MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1678736. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.